Skip to content
healthcare.dev

Carbaglu

NDC 52276-312, Carglumic Acid, tablet, for suspension, from Recordati Rare Diseases.

Product NDC
52276-312
Status
Listed
Labeler
Recordati Rare Diseases
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022562
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52276-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARGLUMIC ACID200 mg/1

Pharmacologic classes

Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]

Package NDCNDC-11Package
52276-312-05522760312055 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-05)
52276-312-605227603126060 TABLET, FOR SUSPENSION in 1 BOTTLE (52276-312-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/10175e73-5172-4dde-a508-8a88b7afc0a1

Use it

Look up 52276-312 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52276-312 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52276-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.